FDA approves encorafenib with binimetinib for metastatic non-small cell lung cancer with a BRAF V600E mutation

https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-encorafenib-binimetinib-metastatic-non-small-cell-lung-cancer-braf-v600e-mutation